- Report
- October 2024
- 186 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 189 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 189 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 199 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 92 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 194 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 137 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- August 2024
- 141 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- July 2024
- 138 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- April 2025
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Clinical Trials
- May 2024
- 80 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- January 2025
- 250 Pages
Global
From €4550EUR$4,999USD£3,900GBP
- Report
- June 2024
- 146 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2024
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- December 2024
United States, Europe, ... United States, Europe, Global, Japan
From €16837EUR$18,500USD£14,434GBP
- Report
- February 2025
Japan, Global, Europe, ... Japan, Global, Europe, United States
From €3413EUR$3,750USD£2,926GBP
- Report
- December 2024
United States
From €2275EUR$2,500USD£1,951GBP
- Report
- December 2024
Mexico, Canada, North America Mexico, Canada, North America
From €8646EUR$9,500USD£7,412GBP
- Report
- February 2025
Middle East
From €4095EUR$4,500USD£3,511GBP

The Fibrin market is a segment of the Hematological Drugs market, which includes drugs used to treat blood-related diseases. Fibrin is a protein that helps the body form blood clots, and is used to treat conditions such as deep vein thrombosis, pulmonary embolism, and bleeding disorders. Fibrin is also used in surgical procedures to help control bleeding.
Fibrin is available in a variety of forms, including topical creams, injectable solutions, and topical gels. It is also available in combination with other drugs, such as anticoagulants and thrombolytics.
The Fibrin market is highly competitive, with many companies offering products in different forms and combinations. Some of the major players in the market include Pfizer, Novo Nordisk, Sanofi, Bayer, and CSL Behring. Show Less Read more